Dr Nguyen Hoa Anh - R&D Director - Chairman of LiveSpo Pharma, is presenting LiveSpo's breakthrough spore probiotics technology at the BIO International Convention 2023, being held from 5th to 8th June 2023 in the US. These technologies feature liquid-form, multi-strain, high-concentration LiveSpo spore probiotics technology, and Pre-activated SPL technology with the product LiveSpo NAVAX which is transformed into nasal spray form.

After undergoing rigorous clinical trials aligned with US standards, LiveSpo NAVAX has emerged as the world's first spore probiotic nasal spray. Its significant impact on reducing treatment duration for acute respiratory infections in children has been proven. LiveSpo NAVAX demonstrates an exceptional ability to reduce the load of Respiratory Syncytial Virus (RSV) by 600-fold and influenza virus by 900-fold. 

During the BIO International Convention, LiveSpo is engaging in B2B meetings with partners coming from various countries all over the world. Discussions will revolve around the potential and practical applications of breakthrough spore probiotics, as well as opportunities for exclusive distribution of LiveSpo products in international markets. 

LiveSpo is the first representative from Vietnam to participate in the BIO International Convention, an exhibition showcasing breakthrough biotechnology solutions, held in Boston, USA. This demonstrates the remarkable development of the Vietnamese pharmaceutical field in the realm of biotechnology.